DK147075C - Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf

Info

Publication number
DK147075C
DK147075C DK481175A DK481175A DK147075C DK 147075 C DK147075 C DK 147075C DK 481175 A DK481175 A DK 481175A DK 481175 A DK481175 A DK 481175A DK 147075 C DK147075 C DK 147075C
Authority
DK
Denmark
Prior art keywords
canamycine
analogy
derivatives
salts
preparation
Prior art date
Application number
DK481175A
Other languages
Danish (da)
English (en)
Other versions
DK147075B (da
DK481175A (da
Inventor
James William Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK481175A publication Critical patent/DK481175A/da
Publication of DK147075B publication Critical patent/DK147075B/da
Application granted granted Critical
Publication of DK147075C publication Critical patent/DK147075C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK481175A 1974-10-26 1975-10-24 Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf DK147075C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4641274 1974-10-26
GB4641274A GB1464401A (en) 1974-10-26 1974-10-26 Aminoglycosides

Publications (3)

Publication Number Publication Date
DK481175A DK481175A (da) 1976-04-27
DK147075B DK147075B (da) 1984-04-02
DK147075C true DK147075C (da) 1984-11-05

Family

ID=10441164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481175A DK147075C (da) 1974-10-26 1975-10-24 Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf

Country Status (28)

Country Link
JP (1) JPS5519237B2 (pl)
AR (1) AR205593A1 (pl)
AT (1) AT340051B (pl)
BE (1) BE834864A (pl)
BG (1) BG24821A3 (pl)
CA (1) CA1039275A (pl)
CH (1) CH601339A5 (pl)
CS (1) CS195712B2 (pl)
DD (1) DD122522A5 (pl)
DE (1) DE2547738C3 (pl)
DK (1) DK147075C (pl)
EG (1) EG11975A (pl)
ES (1) ES442051A1 (pl)
FI (1) FI752951A (pl)
FR (1) FR2289202A1 (pl)
GB (1) GB1464401A (pl)
HU (1) HU172060B (pl)
IE (1) IE42452B1 (pl)
IL (1) IL48263A (pl)
LU (1) LU73644A1 (pl)
NL (1) NL162081C (pl)
NZ (1) NZ179050A (pl)
PH (1) PH12782A (pl)
PL (1) PL99933B1 (pl)
RO (1) RO72878A (pl)
SE (1) SE7511945L (pl)
SU (1) SU617017A3 (pl)
ZA (1) ZA756326B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860513D1 (en) * 1977-06-24 1981-04-09 Scherico Ltd Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
JPS5488241A (en) * 1977-12-21 1979-07-13 Kyowa Hakko Kogyo Co Ltd Novel fortimicin a derivative
JPS57118475U (pl) * 1981-01-14 1982-07-22

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606076A5 (pl) * 1973-08-06 1978-10-13 Scherico Ltd

Also Published As

Publication number Publication date
CA1039275A (en) 1978-09-26
BG24821A3 (en) 1978-05-12
CH601339A5 (pl) 1978-07-14
ZA756326B (en) 1976-09-29
IE42452B1 (en) 1980-08-13
FR2289202A1 (fr) 1976-05-28
JPS5168543A (pl) 1976-06-14
NL162081C (nl) 1980-04-15
PL99933B1 (pl) 1978-08-31
EG11975A (en) 1978-06-30
RO72878B (ro) 1983-06-30
PH12782A (en) 1979-08-17
IL48263A0 (en) 1975-12-31
SE7511945L (sv) 1976-04-27
AU8598175A (en) 1976-12-09
LU73644A1 (pl) 1977-05-31
AR205593A1 (es) 1976-05-14
DK147075B (da) 1984-04-02
IE42452L (en) 1976-04-26
JPS5519237B2 (pl) 1980-05-24
BE834864A (fr) 1976-04-26
RO72878A (ro) 1983-07-07
DE2547738C3 (de) 1978-08-03
NZ179050A (en) 1978-03-06
ATA809575A (de) 1977-03-15
SU617017A3 (ru) 1978-07-25
DK481175A (da) 1976-04-27
CS195712B2 (en) 1980-02-29
DD122522A5 (pl) 1976-10-12
GB1464401A (en) 1977-02-16
FI752951A (pl) 1976-04-27
NL162081B (nl) 1979-11-15
NL7512465A (nl) 1976-04-28
FR2289202B1 (pl) 1978-11-10
DE2547738B2 (de) 1977-12-01
DE2547738A1 (de) 1976-05-06
HU172060B (hu) 1978-05-28
ES442051A1 (es) 1977-04-01
AT340051B (de) 1977-11-25
IL48263A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
DK146595C (da) Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf
DK145341C (da) Analogifremgangsmaade til fremstilling af pyridylguanidiner
DK154289C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller salte deraf
DK144525C (da) Analogifremgangsmaade til fremstilling af 5-halogenpyrimid-2-oner eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK157027C (da) Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-o1-4-carboxylsyreforbindelser eller salte deraf
DK146386C (da) Analogifremgangsmaade til fremstilling af phenylalkanolamin-forbindelser eller salte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK146006C (da) Fremgangsmaade til fremstilling af i 2- og 6-stillingen i phenylringen substituerede 2-phenylamino-2-imidazolin-derivater eller salte deraf
DK145907C (da) Fremgangsmaade til fremstilling af 2-arylamino-2-imidazolin-derivater eller salte deraf
DK147942C (da) Analogifremgangsmaade til fremstilling af kanamycin a- eller kanamycin b-derivater eller syreadditionssalte deraf
DK139724C (da) Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller salte heraf
DK139580B (da) Analogifremgangsmåde til fremstilling af additionssalte af piperidylindolderivater.
DK385777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK159154C (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK144301C (da) Analogifremgangsmaade til fremstilling af penicilliner eller salte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK144697C (da) Analogifremgangsmaade til fremstilling af 3,4-dihydrocarbostyrilderivater eller syreadditionssalte deraf
DK146822C (da) Analogifremgangsmaade til fremstilling af derivater af 4-desacetyl-vinblastin eller salte deraf
DK147075C (da) Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf
DK140841B (da) Analogifremgangsmåde til fremstilling af isoquinolinderivater eller salte deraf.
DK140590B (da) Analogifremgangsmåde til fremstilling af 4-cyclopropylmethylenoxy-3-chlorphenyleddikesyre eller salte heraf.
DK408176A (da) Fremgangsmade til fremstilling af 5-thiazolmethanaminderivater eller salte deraf